mTOR
mTOR inhibitors are compounds that inhibit the activity of Mammalian Target of Rapamycin (mTOR), a central regulator of cell growth, proliferation, metabolism, and survival. The mTOR pathway is frequently altered in cancer and other diseases, making mTOR a critical target for therapeutic intervention. Inhibitors of mTOR are widely used in research related to cancer, aging, and metabolic disorders. At CymitQuimica, we offer a variety of mTOR inhibitors to support your research in signal transduction, oncology, and therapeutic development.
Found 163 products of "mTOR"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
PI3K/mTOR Inhibitor-4
CAS:Oral PI3K/mTOR Inhibitor-4 targets PI3Kα, γ, δ, mTOR; IC50s: 0.63, 22, 9.2, 13.85 nM. Used in cancer research.Formula:C27H22FN3O6SColor and Shape:SolidMolecular weight:535.54PI-540
CAS:PI-540 is a potent and selective inhibitor of class 1A phosphatidylinositide 3-kinases (PI3K).Formula:C22H27N5O2SColor and Shape:SolidMolecular weight:425.55PI3K/mTOR Inhibitor-3
CAS:PI3K/mTOR Inhibitor-3, a potent dual-action anti-cancer imidazoline, targets PI3K and mTOR.Formula:C22H23N5OColor and Shape:SolidMolecular weight:373.45PI3K/mTOR Inhibitor-9
CAS:PI3K/mTOR Inhibitor-9 acts on mTOR (38 nM IC50) and PI3Kα/γ (6.6 nM IC50), PI3Kδ (0.8 nM IC50).Formula:C23H27N7O2Color and Shape:SolidMolecular weight:433.51PI3Ka-IN-5
CAS:PI3Ka-IN-5 is a potent PI3Kα/mTOR inhibitor, with an IC 50 of 0.7 nM and 3.3 nM, respectively. PI3Ka-IN-5 can be used for the research of colorectal cancer .Formula:C30H35N9O5Color and Shape:SolidMolecular weight:601.66NVP-BBD130
CAS:NVP-BBD130 is a stable, ATP-competitive, potent, orally active inhibitor of PI3K and mTOR.Formula:C28H21N5OColor and Shape:SolidMolecular weight:443.5PKI-179 hydrochloride
CAS:PKI-179: oral PI3K/mTOR inhibitor; IC50: PI3Kα/β/δ/γ (8-74 nM), PI3Kα mutants (11-14 nM), mTOR (0.42 nM); selective; inhibits cancer cell growth.Formula:C25H29ClN8O3Color and Shape:SolidMolecular weight:525PI3K/mTOR Inhibitor-8
CAS:PI3K/mTOR Inhibitor-8: Dual PI3Kα (IC50: 0.46 nM) & mTOR (IC50: 12 nM) inhibitor; blocks G1/S phase & induces apoptosis in HCT-116 cells.Formula:C23H22N8O4SColor and Shape:SolidMolecular weight:506.54eCF-309
CAS:eCF-309 is a potent mTOR inhibitor with IC50 value of 15 nM.Formula:C18H21N7O3Color and Shape:SolidMolecular weight:383.4PI3K/mTOR Inhibitor-13
CAS:PI3K/mTOR Inhibitor-13, an oral dual blocker of PI3K and mTOR, may treat sexual diseases, solid tumors, and IPF.Formula:C20H13F2N5O3SColor and Shape:SolidMolecular weight:441.41PI3-Kinase α Inhibitor 2
CAS:Phosphatidylinositol 3-kinase (PI3K) catalyzes the phosphorylation of the 3' hydroxyl position of PIs to produce the second messengers PtdIns-(3,4)-P2 andFormula:C16H15N3O2SColor and Shape:SolidMolecular weight:313.37OXA-01
CAS:OXA-01 is a potent mTORC1 and mTORC2 inhibitor, with IC 50 values of 29 nM and 7 nM, respectively [1]. OXA-01 demonstrates broad anti-tumor activity.Formula:C21H20ClN5O2Color and Shape:SolidMolecular weight:409.87P-2281
CAS:P-2281 is an mTOR inhibitor with anticancer and anti-inflammatory properties.P-2281 inhibits dextran sulfate sodium (DSS)-induced colitis by suppressing T-cellFormula:C9H8ClN3OPurity:99.98%Color and Shape:SolidMolecular weight:209.63PI3K/mTOR Inhibitor-2
CAS:Potent PI3K/mTOR Inhibitor-2 targets PI3Kα/β/δ/γ & mTOR (IC50: 3.4, 34, 16,1, 4.7 nM); exhibits antitumor effects.Formula:C20H13ClF2N4O4SPurity:96.16%Color and Shape:SolidMolecular weight:478.86Ref: TM-T12459
1mg55.00€5mg138.00€10mg215.00€25mg358.00€50mg512.00€100mg692.00€200mg888.00€1mL*10mM (DMSO)144.00€QNN33358
CAS:QNN33358 is an alkylacylglycerol acts as a protein kinase C (PKC) inhibitor and diacylglycerol (DAG) antagonist.Formula:C21H42O4Color and Shape:SolidMolecular weight:358.56WJD008
CAS:WJD008 inhibits PI3K/mTOR, blocks cancer cell growth, and has tumor-fighting properties.Formula:C19H21N5O2Color and Shape:SolidMolecular weight:351.4AP1867
CAS:AP1867 (FK506-binding protein) is a synthetic FKBP12 F36V-directed ligand coupled to THOX derivatives, facilitating targeted protein interactions and intracellular modulation studies.Formula:C38H47NO11Purity:99.86%Color and Shape:SolidMolecular weight:693.78Ref: TM-T14297
1mg150.00€5mg362.00€10mg502.00€25mg947.00€50mg1,487.00€100mg2,164.00€1mL*10mM (DMSO)545.00€PI3Kα/mTOR-IN-1
CAS:PI3Kα/mTOR-IN-1 is a potent dual inhibitor of PI3Kα/mTOR.Formula:C16H18N6OPurity:99.89%Color and Shape:SolidMolecular weight:310.35JR-AB2-011
CAS:JR-AB2-011: selective mTORC2 inhibitor, IC50 = 0.36μM, blocks Rictor-mTOR, Ki = 0.19μM, cytotoxic in glioblastoma.Formula:C17H14Cl2FN3OSPurity:98.33% - 99.41%Color and Shape:SolidMolecular weight:398.28Ref: TM-T11728
1mg90.00€5mg192.00€10mg326.00€25mg597.00€50mg895.00€100mg1,198.00€1mL*10mM (DMSO)212.00€FT-1518
CAS:FT-1518 is an orally available, selective and potent mTORC1 and mTORC2 inhibitor with anticancer and antitumor activity for cancer research.Formula:C20H26N8OPurity:98.34% - 98.80%Color and Shape:SolidMolecular weight:394.47
